GENE

Genetec Technology BerhadKLSE:GENETEC Stock Report

Market Cap

RM1.8b

7D

3.4%

1Y

2,078.3%

Updated

20 Sep, 2021

Data

Company Financials
GENETEC fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends0/6

GENETEC Overview

Genetec Technology Berhad, an investment holding company, designs and manufactures customized factory automation equipment and integrated vision inspection systems primarily in Malaysia.

Price History & Performance

Summary of all time highs, changes and price drops for Genetec Technology Berhad
Historical stock prices
Current Share PriceRM34.20
52 Week HighRM1.51
52 Week LowRM36.48
Beta-0.19
1 Month Change44.55%
3 Month Change509.63%
1 Year Change2,078.34%
3 Year Change1,779.12%
5 Year Change3,286.14%
Change since IPO1,610.00%

Recent News & Updates

Sep 08
The CEO Of Genetec Technology Berhad (KLSE:GENETEC) Might See A Pay Rise On The Horizon

The CEO Of Genetec Technology Berhad (KLSE:GENETEC) Might See A Pay Rise On The Horizon

The decent performance at Genetec Technology Berhad ( KLSE:GENETEC ) recently will please most shareholders as they go...

Aug 05
Genetec Technology Berhad's (KLSE:GENETEC) Robust Earnings Are Not All Good News For Shareholders

Genetec Technology Berhad's (KLSE:GENETEC) Robust Earnings Are Not All Good News For Shareholders

Genetec Technology Berhad's ( KLSE:GENETEC ) stock rose after it released a robust earnings report. Despite the strong...

Jul 30
Genetec Technology Berhad's (KLSE:GENETEC) Returns On Capital Are Heading Higher

Genetec Technology Berhad's (KLSE:GENETEC) Returns On Capital Are Heading Higher

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...

Jun 11
Is Genetec Technology Berhad (KLSE:GENETEC) Using Debt In A Risky Way?

Is Genetec Technology Berhad (KLSE:GENETEC) Using Debt In A Risky Way?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Shareholder Returns

GENETECMY SemiconductorMY Market
7D3.4%3.3%-1.0%
1Y2,078.3%105.1%5.9%

Return vs Industry: GENETEC exceeded the MY Semiconductor industry which returned 105.1% over the past year.

Return vs Market: GENETEC exceeded the MY Market which returned 5.9% over the past year.

Price Volatility

Is GENETEC's price volatile compared to industry and market?
GENETEC volatility
GENETEC Beta-0.19
Industry Beta1.13
Market Beta1

Stable Share Price: GENETEC is more volatile than 90% of MY stocks over the past 3 months, typically moving +/- 16% a week.

Volatility Over Time: GENETEC's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of MY stocks.

About the Company

FoundedEmployeesCEOWebsite
1997n/aKem Chinhttps://www.genetec.net

Genetec Technology Berhad, an investment holding company, designs and manufactures customized factory automation equipment and integrated vision inspection systems primarily in Malaysia. The company also provides value-added services for automotive-electric vehicles and internal combustion engines, hard disk drive (HDD), electronics, pharmaceutical, semiconductor, and home appliance industries. In addition, it fabricates machine parts and toolings for equipment and replications of systems and equipment.

Valuation

Is Genetec Technology Berhad undervalued compared to its fair value and its price relative to the market?

292.03x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate GENETEC's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate GENETEC's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: GENETEC is poor value based on its PE Ratio (292x) compared to the MY Semiconductor industry average (64.4x).

PE vs Market: GENETEC is poor value based on its PE Ratio (292x) compared to the MY market (16.4x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate GENETEC's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: GENETEC is overvalued based on its PB Ratio (17.3x) compared to the MY Semiconductor industry average (5.1x).


Future Growth

How is Genetec Technology Berhad forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

21.1%

Forecasted Semiconductors industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Genetec Technology Berhad has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Genetec Technology Berhad performed over the past 5 years?

7.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: GENETEC has a high level of non-cash earnings.

Growing Profit Margin: GENETEC became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: GENETEC's earnings have grown by 7.4% per year over the past 5 years.

Accelerating Growth: GENETEC has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: GENETEC has become profitable in the last year, making it difficult to compare its past year earnings growth to the Semiconductor industry (68.1%).


Return on Equity

High ROE: GENETEC's Return on Equity (5.2%) is considered low.


Financial Health

How is Genetec Technology Berhad's financial position?


Financial Position Analysis

Short Term Liabilities: GENETEC's short term assets (MYR127.5M) exceed its short term liabilities (MYR57.0M).

Long Term Liabilities: GENETEC's short term assets (MYR127.5M) exceed its long term liabilities (MYR10.1M).


Debt to Equity History and Analysis

Debt Level: GENETEC's debt to equity ratio (27.3%) is considered satisfactory.

Reducing Debt: GENETEC's debt to equity ratio has reduced from 28% to 27.3% over the past 5 years.

Debt Coverage: GENETEC's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: GENETEC's interest payments on its debt are well covered by EBIT (6.5x coverage).


Balance Sheet


Dividend

What is Genetec Technology Berhad current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate GENETEC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate GENETEC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if GENETEC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if GENETEC's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: GENETEC is not paying a notable dividend for the MY market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of GENETEC's dividend in 3 years as they are not forecast to pay a notable one for the MY market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

11.9yrs

Average management tenure


CEO

Kem Chin (51 yo)

23.92yrs

Tenure

RM553,382

Compensation

Mr. Kem Weng Chin serves as the Managing Director of Genetec Technology Sdn. Bhd. at ATIS Corporation Berhad since October 27, 1997.Mr. Chin joined Applied Magnetics Malaysia Sdn Bhd (Disc Drive Recording...


CEO Compensation Analysis

Compensation vs Market: Kem's total compensation ($USD132.66K) is below average for companies of similar size in the MY market ($USD302.22K).

Compensation vs Earnings: Kem's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: GENETEC's management team is seasoned and experienced (11.9 years average tenure).


Board Members

Experienced Board: GENETEC's board of directors are considered experienced (8.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.1%.


Top Shareholders

Company Information

Genetec Technology Berhad's employee growth, exchange listings and data sources


Key Information

  • Name: Genetec Technology Berhad
  • Ticker: GENETEC
  • Exchange: KLSE
  • Founded: 1997
  • Industry: Semiconductor Equipment
  • Sector: Semiconductors
  • Market Cap: RM1.760b
  • Shares outstanding: 51.45m
  • Website: https://www.genetec.net

Location

  • Genetec Technology Berhad
  • Seksyen 10
  • Lot 7, Jalan P10/11
  • Bandar Baru Bangi
  • Selangor
  • 43650
  • Malaysia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/20 15:30
End of Day Share Price2021/09/20 00:00
Earnings2021/06/30
Annual Earnings2021/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.